|
Volumn 24, Issue 3, 2004, Pages 731-736
|
Control of gene therapy by MDR1 and EGR1 promoter sequences in transcriptional targeting by chemotherapy (Review).
a a a a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
CYTOTOXIN;
DNA;
DNA BINDING PROTEIN;
EARLY GROWTH RESPONSE FACTOR 1;
EGR1 PROTEIN, HUMAN;
GLYCOPROTEIN P;
IMMEDIATE EARLY PROTEIN;
TRANSCRIPTION FACTOR;
TUMOR NECROSIS FACTOR ALPHA;
ANIMAL;
BIOLOGICAL MODEL;
CLINICAL TRIAL;
DNA DAMAGE;
GENE EXPRESSION REGULATION;
GENE THERAPY;
GENETIC TRANSCRIPTION;
GENETICS;
HUMAN;
IONIZING RADIATION;
METABOLISM;
METHODOLOGY;
PROMOTER REGION;
REVIEW;
ANIMALS;
CLINICAL TRIALS;
CYTOTOXINS;
DNA;
DNA DAMAGE;
DNA-BINDING PROTEINS;
EARLY GROWTH RESPONSE PROTEIN 1;
GENE EXPRESSION REGULATION, NEOPLASTIC;
GENE THERAPY;
HUMANS;
IMMEDIATE-EARLY PROTEINS;
MODELS, BIOLOGICAL;
P-GLYCOPROTEIN;
PROMOTER REGIONS (GENETICS);
RADIATION, IONIZING;
TRANSCRIPTION FACTORS;
TRANSCRIPTION, GENETIC;
TUMOR NECROSIS FACTOR-ALPHA;
MLCS;
MLOWN;
|
EID: 6044219988
PISSN: 10196439
EISSN: None
Source Type: Journal
DOI: 10.3892/ijo.24.3.731 Document Type: Review |
Times cited : (5)
|
References (53)
|